RecruitingPhase 2NCT06138964

Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars

Randomized Intra-individually Controlled Double-blinded Trial Comparing Effect of Small Interfering RNA Against SPARC (siSPARC) Microneedle Patch Versus Small Interfering RNA Against SPARC and IL4-RA (siSPARC + siLR4A) Microneedle Patch on Appearance of Post-surgical Scars


Sponsor

National Skin Centre

Enrollment

50 participants

Start Date

Nov 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized, double-blind controlled study aims to compare the effect on appearance of post- surgical scars between daily application of siSPARC microneedle patch versus siSPARC + siLR4A microneedle patches. These are patches comprising short microneedles embedded with hydrolysed RNA (siRNAs).


Eligibility

Min Age: 21 YearsMax Age: 75 Years

Inclusion Criteria5

  • Adult
  • Age 21-75
  • weeks (+/- 7 days) after surgical operation with incision into the dermis
  • Post-stitch removal when stitches were applied
  • Wound closure/union achieved

Exclusion Criteria5

  • Pregnant or lactating participant
  • Participants with wound infection
  • Participants assessed to be uncooperative or unable to self-administer the interventions
  • Participants with known contact allergy to ingredients in the patch formulation (comprising hyaluronic acid, siRNA and glue) and/or isopropyl alcohol
  • Participants who are unable to personally consent (for e.g., cognitively impaired)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGsiSPARC + siLR4A microneedle patches

siSPARC + siLR4A microneedle patch

DRUGsiSPARC microneedle patch

siSPARC microneedle patch


Locations(1)

National Skin Centre

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06138964


Related Trials